---
title: "Investors: Talk to the Founder | Trelice"
description: "Interested in investing in Trelice, the protocol authoring platform for clinical trials? Send a short note and the founder will reply."
canonical_url: "https://www.trelice.com/investors"
---

Investors

# Invest in how clinical protocols *get written.*

Trelice is the protocol authoring platform for clinical trials. Teams write the protocol once, and the documents that depend on it are generated from the approved version. If you would like to talk about investing, send a note and Ilan will reply.

[Get in touch](#investor-contact)

Why Trelice

## What we are building.

### Every trial starts with a protocol

Most protocols are still written in Word. When the protocol changes, the consent form, visit worksheets and other study documents are updated by hand.

### Built on the industry template

Trelice is native to ICH M11, the harmonized protocol template, and exports a CDISC USDM study definition.

### The team

Ilan Slonim, an engineer from Unit 8200 and Zuora, built Trelice after years of hearing about clinical operations work at his own dinner table. Temitope Keyes, in clinical research since 1999, leads sales as a consultant.

[Meet the team](/about#team)

Contact

## Get in touch

Four fields. Ilan reads every note himself.

## A first call

We walk through the problem, the product on a real protocol, and where the company is going. Thirty minutes.

## Prefer email?

Skip the form and write to us directly.

[investors@trelice.com](mailto:investors@trelice.com?subject=Investing%20in%20Trelice)
